Mood Stabilizers and the Influence on Global Leukocyte DNA Methylation in Bipolar Disorder

Citations Over Time

Abstract

Little is known about the relationship between treatments for bipolar disorder (BD), their therapeutic responses and the DNA methylation status. We investigated whether global DNA methylation levels differ between healthy controls and bipolar patients under different treatments. Global DNA methylation was measured in leukocyte DNA from bipolar patients under lithium monotherapy (n = 29) or combination therapy (n = 32) and from healthy controls (n = 26). Lithium response was assessed using the Alda scale. Lithium in monotherapy was associated with hypomethylation (F = 4.63, p = 0.036). Lithium + valproate showed a hypermethylated pattern compared to lithium alone (F = 7.27, p = 0.011). Lithium response was not associated with DNA methylation levels. These data suggest that the choice of treatment in BD may lead to different levels of global DNA methylation. However, further research is needed to understand its clinical significance.

Related Papers

• → Global methylation profiles in DNA from different blood cell types(2011)132 cited
• → New DNA Methylation Markers and Global DNA Hypomethylation Are Associated with Oral Cancer Development(2015)76 cited
• → Progressive age-dependent DNA methylation changes start before adulthood in mouse tissues(2010)47 cited
• → Changes of DNA methylation of Isoetes sinensis under Pb and Cd stress(2018)15 cited
• → Predicting the progress of colon cancer by DNA methylation markers of the p16 gene in feces - Evidence from an animal model(2013)3 cited